255 related articles for article (PubMed ID: 29047146)
1. Incidence and risk factors of colorectal cancer based on 56 324 health checkups: A 7-year retrospective cohort study.
Fujii T; Ohisa M; Sako T; Harakawa T; Sakamune K; Nagashima S; Sugiyama A; Matsuura Y; Tanaka J
J Gastroenterol Hepatol; 2018 Apr; 33(4):855-862. PubMed ID: 29047146
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study.
Tanaka K; Sobue T; Zha L; Kitamura T; Sawada N; Iwasaki M; Inoue M; Yamaji T; Tsugane S
J Epidemiol; 2023 Feb; 33(2):91-100. PubMed ID: 34053963
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
4. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
5. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
6. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer in Italy: 2004 survey.
Zorzi M; Grazzini G; Senore C; Vettorazzi M
Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
[TBL] [Abstract][Full Text] [Related]
9. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
Heresbach D; Manfredi S; D'halluin PN; Bretagne JF; Branger B
Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):427-33. PubMed ID: 16538116
[TBL] [Abstract][Full Text] [Related]
10. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
[TBL] [Abstract][Full Text] [Related]
11. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
[TBL] [Abstract][Full Text] [Related]
13. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
14. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
15. Effect of faecal occult blood positivity on detection rates and positive predictive value of CT colonography when screening for colorectal neoplasia.
Plumb AA; Taylor SA; Halligan S
Clin Radiol; 2015 Oct; 70(10):1104-9. PubMed ID: 26145187
[TBL] [Abstract][Full Text] [Related]
16. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
17. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
20. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]